ArticleScientific reports2024
A novel heterogeneous biocatalyst based on graphene oxide for synthesis of pyran derivatives.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 15 citations in OpenAlex.
- Green protocol for the synthesis of 2-amino-4RSC advances · 2025Article
- Immobilization of CuO onto melamine functionalized magnetic nanocomposite: an efficient catalyst for the Preparation of benzimidazole compounds.Scientific reports · 2025Article
- Dual acid-base catalysis with biologically modified graphene oxide: a sustainable route to polyhydroquinolines with antimicrobial properties.Scientific reports · 2025Article
- Facile synthesis of novel acidic modified magnetic graphene oxide and its application in the green synthesis of pyrimido[4,5-b]quinolines.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Graphene oxide modified with tryptophan (GO-Trp) has been introduced as a new heterogeneous acid-base biocatalyst for synthesis of some pyran derivatives. GO was prepared according to the Hummer's method and tryptophan as a low-cost green amino acid is covalently bonded to the surface of GO without any organic or toxic reagents in a green way. The new catalyst was characterized by different spectroscopic methods such as Fourier transform infrared, X-ray diffraction (XRD), etc. …. The results of XRD patterns showed an increase in the distance between the GO plates in the presence of the modifying agent which specifies the presence of amino acid between the GO layers. XPS analysis also confirmed successful modification through the presence of C-N bonds in the structure of the catalyst. In addition, improvements in thermal stability and changes in the morphology of the samples were observed using thermogravimetric analysis and Field emission scanning electron microscopy analysis respectively. Evaluation of the catalyst performance in the synthesis of some benzo[b]pyran and pyrano[3,2-c] chromene derivatives showed presentable results. Seven benzo[b]pyran (4a-4g) and five pyrano[3,2-c] chromene (4h-4l) derivatives were synthesized. GO-Trp as a safe, natural and efficient catalyst, could be reused up to 5 runs for synthesis of pyran derivatives without any significant decrease in its potency. High purity of the products and desirable yields are other points that make the present work more attractive.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.